ROPIVACAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ropivacaine, and when can generic versions of Ropivacaine launch?
Ropivacaine is a drug marketed by Amneal, Anthea Pharma, Caplin, Eugia Pharma, Gland, Hikma, Hospira, Inforlife, Kindos, Mylan Labs Ltd, Navinta Llc, Rising, and Somerset Theraps Llc. and is included in sixteen NDAs.
The generic ingredient in ROPIVACAINE is ropivacaine hydrochloride. There are thirteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ropivacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ropivacaine
A generic version of ROPIVACAINE was approved as ropivacaine hydrochloride by NAVINTA LLC on July 17th, 2014.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ROPIVACAINE?
- What are the global sales for ROPIVACAINE?
- What is Average Wholesale Price for ROPIVACAINE?
Summary for ROPIVACAINE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 16 |
| Drug Prices: | Drug price information for ROPIVACAINE |
| DailyMed Link: | ROPIVACAINE at DailyMed |
US Patents and Regulatory Information for ROPIVACAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inforlife | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 206166-003 | Jun 11, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hospira | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 090194-001 | Sep 23, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Labs Ltd | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 206091-001 | Oct 26, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Somerset Theraps Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 207636-001 | Jun 15, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
